Maxim Group initiated coverage on NeuroSense Therapeutics with a new price target

1/7/22 9:27:00 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Maxim Group initiated coverage of NeuroSense Therapeutics with a rating of Buy and set a new price target of $7.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$NRSN

Date	Price Target	Rating	Analyst
1/7/2022	$7.00	Buy	Maxim Group